Please login to the form below

Not currently logged in


This page shows the latest Herpes news and features for those working in and with pharma, biotech and healthcare.

Gilead continues its exec clear-out, licenses antivirals from Novartis

Gilead continues its exec clear-out, licenses antivirals from Novartis

agents to treat human rhinovirus, influenza and herpes viruses.

Latest news

More from news
Approximately 6 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    contain the adjuvant QS-21 Stimulon.  In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.  GSK's malarial vaccine, Mosquirix which also contains

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    10. ‡‡BioAlliance Pharma/ Innocutis. Licence. Sitavig (acyclovir Lauriad) for recurrent herpes labialis (approved).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...